22840-1653 : Cladosporium Herbarum .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution
| NDC: | 22840-1653 |
| Labeler: | Greer Laboratories, Inc. |
| Product Type: | Non-standardized Allergenic |
| Drug Name: | Cladosporium Herbarum |
| Dosage Form: | Intradermal; Percutaneous; Subcutaneous Solution |
| Application #: | BLA101833 |
| Rev. Date: |
NDC Package Codes:
- 22840-1653-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑1653‑2)
- 22840-1653-4: 50 ML IN 1 VIAL, MULTI‑DOSE (22840‑1653‑4)
Active Ingredients:
- Cladosporium Herbarum
Dosage Strength:
- .05 g/mL
Pharmaceutical Classes:
- Allergens [CS]
- Cell-mediated Immunity [PE]
- Fungal Proteins [CS]
- Increased Histamine Release [PE]
- Increased IgG Production [PE]
- Non-Standardized Fungal Allergenic Extract [EPC]
Related Products:
Based on records with the same trade name.- 22840-1654 Cladosporium Herbarum 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-1656 Cladosporium Herbarum .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-1657 Cladosporium Herbarum 40000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-5613 Cladosporium Herbarum .025 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 49288-0158 Cladosporium Herbarum .1 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
- 49288-0159 Cladosporium Herbarum .05 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 22840-1651Next: 22840-1654 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
